Detalhe da pesquisa
1.
Single-cell landscape of idiopathic multicentric Castleman disease in identical twins.
Blood
; 143(18): 1837-1844, 2024 May 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38170173
2.
A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma.
Blood
; 138(6): 452-463, 2021 08 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33728448
3.
A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort.
Am J Hematol
; 97(9): 1159-1169, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35726449
4.
Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study.
Lancet Oncol
; 17(9): 1240-7, 2016 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-27470079
5.
An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphoma.
Sci Transl Med
; 14(667): eabn7824, 2022 10 19.
Artigo
Inglês
| MEDLINE | ID: mdl-36260690
6.
Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.
Leukemia
; 35(4): 1225, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33686199
7.
Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.
Leukemia
; 34(12): 3413-3419, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32753688